A study to assess the effectiveness and safety of the Fluocinolone-acetonide intravitreal implant, in patients with persistent or recurrent DME despite treatment, after treatment with at least 1 dexamethasone implant
Latest Information Update: 22 Jan 2021
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Jan 2021 New trial record